A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-03-05) →
What happened
G2Gbio disclosed convertible bonds to raise US$52M, about 13.7% of its market value.
For context, this raise equals about 13.7% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$52M |
| vs. market value | 13.7% |
| Filed | 2026-02-23, Material event report (rights offering) |
| Source | DART rcept 20260223004119 → open original filing |
Versions of this filing
- 2026-02-23Original (this page)
- 2026-03-05Amendment 1
Source: DART. Information only, not investment advice.